Central Giant Cell Granuloma of the Jaws Complicated with Hemorrhagic Hypovolemic Shock: A Case Report
Central Giant Cell Granuloma of the Jaws Complicated with Hemorrhagic Hypovolemic Shock: A Case Report
Central giant cell granulomas (CGCGs) are benign but potentially aggressive growths of fibrous tissue, more common in pediatric patients. These granulomas, which are rare and account for less than 7% of benign maxillary tumors, often appear in the mandible. Surgical removal is the primary treatment for aggressive CGCGs, with a favorable prognosis if complete excision is achieved.
Pioneering science insights.
Innoscience Journal (Inno J) is a new global platform dedicated to advancing medical knowledge and innovation. Our unwavering commitment to fostering a healthier world fuels our mission.
We are dedicated to enhancing patient outcomes by facilitating the exchange of knowledge and expertise, ultimately leading to more informed decisions and improved healthcare systems.
Our journal serves as a beacon of enlightenment for medical professionals, researchers, and scholars, providing a space where cutting-edge research and discoveries can be shared. Through rigorous peer review and a commitment to excellence, Innoscience Journal aims to empower the medical community with the latest insights and evidence-based practices.
Join us in our quest to push the boundaries of medical understanding and contribute to a world where healthcare is guided by the best available knowledge, ensuring better outcomes for all.
Innoscience Journal takes pride in its outstanding indexing across major academic databases and search engines. Our commitment to excellence is reflected in our presence in prestigious scientific journal databases, ensuring that papers published in our journal are widely recognized and accessible to the global community of researchers and healthcare professionals.
We understand the importance of timely dissemination of medical and scientific research. Our review and publication process is carried out efficiently, enabling a rapid publication of accepted articles. This means that authors can share their findings with the world more swiftly, contributing to the ongoing evolution of medical knowledge.
Recognizing the diversity of the global medical and scientific community, Innoscience Journal is published with two languages, facilitating communication and knowledge exchange among researchers from different cultures and regions. Our bilingual journal promotes an inclusive and global approach to medical research, expanding the reach and influence of articles published on our platform.
All papers submitted to this journal will be examined, evaluated and will have their merits judged by external evaluators, and authors will be notified of the acceptance or refusal of their work.
If the article is denied, the author will be given a new evaluation for the next edition.
Before submitting for peer review, authors must submit a Letter of Originality and Assignment of Rights, duly signed by all authors.
The basic content of this letter must include, besides the date, city and signature of the authors, the text: "We, (fill in the authors name, institutional link, CPF and full address), authors of the article" "We hereby declare the originality of this document submitted and declare that it has not been submitted to another journal and will not be submitted, if it is accepted and published by the South Florida Journal of Development.
FIGHT AGAINST PLAGUE: All articles received are previously evaluated by the editor-in-chief. If plagiarism is suspected, the article is automatically declined.
If published, the authors assign the copyright and publication rights of their articles to the InnoJ